Effect of remimazolam for general anesthesia on postoperative nausea and vomiting : A systematic review and meta-analysis.

Su Yeon KimKyu Man SimHyo-Seok NaBon-Wook KooHyun-Jung Shin

Published in: Die Anaesthesiologie (2024)

Remimazolam did not increase PONV risk compared to propofol and reduced PONV incidence compared to volatile agents, with higher participant satisfaction. To validate the present findings, further well-planned large clinical trials are required.

Keyphrases

clinical trial
patients undergoing
risk factors
phase ii
open label
breast cancer risk